DG
6
2
XRAY
28
2
DVN
21
3
SLB
55
2
LMT
34
2
RIG
60
2
WBA
48
4
ROST
63
12
SIG
52
3
MAT
46
12
LH
43
-2
NDAQ
62
2
ROP
62
3
BBY
46
10
CL
58
2
PFG
45
3
CSX
60
3
AN
58
4
RSG
71
3
AVY
53
3
DG
6
2
XRAY
28
2
DVN
21
3
SLB
55
2
LMT
34
2
RIG
60
2
WBA
48
4
ROST
63
12
SIG
52
3
MAT
46
12
LH
43
-2
NDAQ
62
2
ROP
62
3
BBY
46
10
CL
58
2
PFG
45
3
CSX
60
3
AN
58
4
RSG
71
3
AVY
53
3
Financhill
Back

GlycoMimetics Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
47

GLYC
GlycoMimetics

Last Price:
0.32
Seasonality Move:
11.03%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%
Sell
47
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

  • The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

  • The GlycoMimetics share price today is $0.32
    The current trend is moderately bearish and GLYC is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $64.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

GLYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 47.47 Sell
Chaikin Money Flow: -460494 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.24 - 0.44) Sell
Bollinger Bands (100): (0.14 - 0.32) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.96 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 518116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.94 - 69.24) Sell
Bollinger Bands (100): (67.93 - 87.19) Sell

GLYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.37 Sell
20-day SMA: 0.39 Sell
50-day SMA: 0.25 Buy
200-day SMA: 0.96 Sell
8-day EMA: 0.36 Sell
20-day EMA: 0.35 Sell
50-day EMA: 0.3 Buy
200-day EMA: 0.74 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.73 Buy
20-day SMA: 65.69 Sell
50-day SMA: 68.56 Sell
200-day SMA: 81.05 Sell
8-day EMA: 63.9 Buy
20-day EMA: 65.57 Sell
50-day EMA: 69.74 Sell
200-day EMA: 79.39 Sell

GlycoMimetics Earnings Growth & GLYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

GlycoMimetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):